Crestline Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-52,357
Closed -$2.75M 349
2021
Q4
$2.75M Sell
52,357
-8,738
-14% -$475K 0.21% 99
2021
Q3
$3.66M Buy
+61,095
New +$3.77M 0.34% 58
2018
Q3
Sell
-26,890
Closed -$1.4M 244
2018
Q2
$1.4M Buy
+26,890
New +$1.41M 0.15% 172
2017
Q3
Sell
-18,022
Closed -$1.39M 181
2017
Q2
$1.39M Buy
+18,022
New +$1.35M 0.19% 63
2016
Q4
Sell
-7,142
Closed -$476K 214
2016
Q3
$476K Buy
+7,142
New +$455K 0.06% 148

Other funds holding NUVA

Crestline Management's NUVA Position: Q1 2022 in Review

Crestline Management sold out of NuVasive, Inc. (NUVA) in Q1 2022, closing a stake of 52,357 shares — an estimated $2.75M sold.

Crestline Management first reported a position in NUVA in Q3 2016 and held it in 5 quarters. The position peaked at $3.66M in Q3 2021. 245 funds tracked by Wall St. Rank hold NUVA as of Q1 2022.

  • Crestline Management reported no remaining NuVasive, Inc. position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 52,357 NuVasive, Inc. shares in Q1 2022, an estimated $2.75M.
  • Crestline Management first reported a position in NuVasive, Inc. in Q3 2016 and held it in 5 quarters.
  • Crestline Management's NuVasive, Inc. position peaked at $3.66M in Q3 2021.
  • 245 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.